Wilmslow Estates Ltd → Ocugen, Inc. OCGN

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

0 buys · 2 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-09-30

DTC 13.66

102,053,118 shares short · -3.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $575K

Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-09	Musunuri Shankar	director, officer	Sale	468,727	$1.12	$525K
2026-09-09	Musunuri Shankar	director, officer	Sale	57,264	$1.12	$64K

Other 13D/G Filings on Ocugen, Inc.

Filed	Form	Filer	Stake	Shares
2019-02-12	SC	Wilmslow Estates Ltd	—	—	view →
2019-01-15	SC	KIRK RANDAL J	—	—	view →
2019-01-03	SC	SPLIT ROCK PARTNERS II, LP	—	—	view →
2018-01-08	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by Wilmslow Estates Ltd

Filed	Form	Issuer	Stake	Shares
2019-02-12	SC	HISTOGENICS CORP OCGN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →